Literature DB >> 10532737

Effect of graded anterior transposition of the inferior oblique muscle on versions and vertical deviation in primary position.

A Guemes1, K W Wright.   

Abstract

INTRODUCTION: There are various methods for weakening the inferior oblique muscle; here we describe the results of a graded anterior transposition.
METHODS: Charts of 21 children (37 eyes) who underwent graded anterior transposition of the inferior oblique muscle were reviewed. Graded anterior transposition consisted of reinsertion of the inferior oblique muscle at various points along the temporal aspect of the inferior rectus muscle; the more severe the overaction, the more anterior the placement of the new insertion. In all cases the new inferior oblique insertion line was oriented parallel to the inferior rectus muscle axis. We analyzed the preoperative to postoperative change in inferior oblique overaction (versions) and vertical alignment in primary position.
RESULTS: Postoperatively, 18 of 21 patients had normal versions, 2 patients had -1 underaction of 1 eye, and 1 patient had +1 overaction of both eyes. Eleven patients (15 eyes) had a preoperative vertical deviation in primary position of 4 PD or more. Three of these patients had unilateral congenital superior oblique palsy and a preoperative hypertropia of 20 PD. They underwent unilateral graded anterior transposition with a mean postoperative vertical change of 18 PD. Three patients had asymmetric primary inferior oblique overaction with true hypertropia, 1 patient had amblyopia and primary inferior oblique overaction, and 4 patients had dissociated vertical deviation associated with inferior oblique overaction. All patients had improvement after surgery, with no significant vertical deviation in primary position.
CONCLUSIONS: Graded anterior transposition of the inferior oblique muscle is effective in normalizing versions and correcting vertical deviations in primary position.

Entities:  

Mesh:

Year:  1998        PMID: 10532737     DOI: 10.1016/s1091-8531(98)90053-2

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  8 in total

1.  Effect of bilateral inferior oblique partial myectomy on V pattern exotropia with inferior oblique overaction.

Authors:  Tianke Yang; Chunwen Chen; Wenxiu Ma; Yubing Duan; Qin Zhu; Jingyan Yao
Journal:  BMC Ophthalmol       Date:  2022-05-21       Impact factor: 2.086

2.  Dose-response relationship in inferior oblique muscle recession.

Authors:  Miriam Metten; Heike Link; Flemming Staubach; Michael Bach; Wolf A Lagrèze
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-06       Impact factor: 3.117

3.  Asymmetric inferior oblique anterior transposition for incomitant asymmetric dissociated vertical deviation.

Authors:  Stacy L Pineles; Guillermo Velez; Federico G Velez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-24       Impact factor: 3.117

Review 4.  Interventions for dissociated vertical deviation.

Authors:  Sarah R Hatt; Xue Wang; Jonathan M Holmes
Journal:  Cochrane Database Syst Rev       Date:  2015-11-20

5.  The effect of graded recession and anteriorization on unilateral superior oblique palsy.

Authors:  Kun Moon; Se-Youp Lee
Journal:  Korean J Ophthalmol       Date:  2006-09

6.  Effect of modified graded recession and anteriorization on unilateral superior oblique palsy: a retrospective study.

Authors:  Dong Cheol Lee; Se Youp Lee
Journal:  BMC Ophthalmol       Date:  2017-03-14       Impact factor: 2.209

7.  Comparing graded anterior transposition with myectomy in primary inferior oblique overaction - A clinical trial.

Authors:  Reza Nabie; Shalaleh Raoufi; Elmira Hassanpour; Leila Nikniaz; Banafsheh Kharrazi; Shokooh Mamaghani
Journal:  J Curr Ophthalmol       Date:  2019-05-08

8.  The effect of anterior transposition of the inferior oblique muscle on eyelid configuration and function.

Authors:  Tugba Goncu; Sevim Cakmak; Ali Akal; Halit Oguz
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.